Best compounding pharmacy for semaglutide
This is a question with a false premise, and the honest answer is more useful than a ranking would be: you do not choose the pharmacy. You choose a telehealth provider, that provider routes your prescription to a pharmacy it has a relationship with, and you find out which one — if ever — when the vial arrives. The real decision is whether to use a provider that names its pharmacy up front, because a named pharmacy is one you can check.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
The pharmacies actually named, and how they check out
Every pharmacy below was read off a provider’s own public page. Each was then searched against FDA’s list of facilities registered as 503B outsourcing facilities — the register that carries inspection dates and outcomes.
| Pharmacy | Location | Named by | In FDA's 503B register? |
|---|---|---|---|
| RedRock Pharmacy | St. George, UT | SnagRx, Embody, Remevi | Not in FDA's 503B register |
| Health Warehouse | Florence, KY | SnagRx, Embody, Remevi | Not in FDA's 503B register |
| Precision Compounding Pharmacy | Bellmore, NY | SnagRx, Embody (Remevi names a pharmacy in the same town) | Not in FDA's 503B register |
| Triad Rx | Daphne, AL | SnagRx, Embody, Remevi | Not in FDA's 503B register |
What that column actually means
Federal law splits compounders in two. Drugs compounded in a 503B outsourcing facility are subject to current good manufacturing practice requirements, and those facilities are primarily overseen by FDA and inspected on a risk-based schedule. Drugs compounded under section 503A in a state-licensed pharmacy are not subject to CGMP, and FDA inspects those pharmacies for cause rather than on a schedule. Neither category produces an FDA-approved drug. The full picture is in 503A vs 503B compounding pharmacies.
So the four pharmacies above are 503A — which is not a secret, and not something the providers hide. SnagRx states directly that its pharmacies are US-based 503A compounding pharmacies, and Embody describes its partners as state-licensed 503A pharmacies. The register check simply confirms from the other side what they already say.
The practical consequence is that there is no federal inspection record to read for any of them. That is worth knowing before you assume a named pharmacy is a vetted one. Naming is a real transparency win; it is not the same as external verification.
The providers that name a pharmacy at all
Most do not. These three do, and the disclosures below were read off their live sites.
SnagRx
Operating entity: Modern Metabolic Medicine, Inc.Names all four partner pharmacies in its footer with street addresses and phone numbers, and states plainly that they are US-based 503A compounding pharmacies.
Embody
Operating entity: Modern Metabolic Medicine, Inc.Names the same four pharmacies with addresses, phone numbers and links, and describes them as state-licensed 503A compounding pharmacies.
Remevi
Operating entity: REMEVi LLC (Nevada)Names its pharmacies with city and state under the heading “We name our pharmacies,” says the name is printed on your vial label, and carries a “503A/503B pharmacies” badge.
Two of those brands are one company. SnagRx and Embody both operate under Modern Metabolic Medicine, Inc. and name an identical set of four pharmacies; Remevi is a separate Nevada company that names the same cluster. Switching between consumer brands does not necessarily change who prepares your medication — which is a good reason to compare on the operating entity rather than the logo.
How to check this yourself, in three steps
- Ask for the name before you pay. A provider that will not tell you which pharmacy prepares your prescription has ended the inquiry there. This is a reasonable question and a routine one.
- Search FDA’s registered outsourcing facility list. It is public, updated weekly, and shows each 503B facility’s last inspection date, whether a Form 483 was issued, whether a recall was conducted, and the action taken based on the last inspection. The table is here.
- Read the absence correctly. Not on the list means not a registered 503B, so CGMP and scheduled federal inspection do not apply — it does not mean unlicensed. Verification of a 503A pharmacy runs through its state board of pharmacy instead.
Also worth asking for: a certificate of analysis for your batch. What one should contain, and what a useless one looks like, is covered in how to read a certificate of analysis.
Keep comparing
For the providers themselves rather than their pharmacies, see the best compounded semaglutide providers and the cheapest semaglutide providers. For what compounded semaglutide is and how its legal footing changed, read compounded vs branded GLP-1s. And if you are weighing the compounded route against a tablet, see GLP-1 pill vs injection. Back to the full GLP-1 provider roundup.
Common questions
- What is the best compounding pharmacy for semaglutide?
- It is not a choice you get to make. Compounding pharmacies dispense against a prescription routed to them by the provider who wrote it, so you select a telehealth provider and the provider selects the pharmacy. The decision actually available to you is whether to use a provider that names its pharmacy — because a named pharmacy can be looked up and an unnamed one cannot.
- Which telehealth providers name their compounding pharmacy?
- Verified on their own live sites in August 2026: SnagRx and Embody each name four partner pharmacies with street addresses and phone numbers — RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy and Triad Rx — and Remevi names its pharmacies with city and state and says the name is printed on the vial label. Most providers name none.
- Are the pharmacies making compounded semaglutide 503A or 503B?
- The ones named by these providers are 503A. None of the four appears in FDA's register of 503B outsourcing facilities, and SnagRx and Embody both state directly that their pharmacies are 503A. That matters because drugs compounded in a 503B outsourcing facility are subject to current good manufacturing practice requirements and FDA inspection on a risk-based schedule, while 503A compounding is not.
- How do I check a compounding pharmacy myself?
- Ask the provider for the pharmacy's name before you pay. Then search FDA's public list of registered outsourcing facilities, which shows each 503B facility's last inspection date, whether a Form 483 was issued, whether a recall was conducted and the action taken. If the pharmacy is not on that list it is not a registered 503B, which tells you the applicable quality regime — and if the provider will not give you a name, there is nothing to check at all.
- Is a 503A pharmacy unsafe?
- No. 503A compounding is a lawful, state-licensed category and many such pharmacies operate to high standards. The distinction is one of external verification rather than a verdict: 503A pharmacies are overseen day to day by state boards, with FDA conducting surveillance and for-cause inspections rather than scheduled ones, so there is no federal inspection record for you to read.
- Do different semaglutide brands use the same pharmacy?
- Frequently, yes. SnagRx and Embody name an identical set of four pharmacies and share a corporate parent, Modern Metabolic Medicine, Inc. Remevi, a separate Nevada company, names the same cluster. Several consumer-facing brands can route to the same dispensing pharmacies, so switching brands does not necessarily change who prepares your medication.